Advertisement
Screener

AMERICAN SHARED HOSPITAL SERVICES (AMS) Deferred State and Local Income Tax Expense (Benefit)

1.9 / 5 stars · 38/102 Roast Me

AMERICAN SHARED HOSPITAL SERVICES Deferred State and Local Income Tax Expense (Benefit)

AMERICAN SHARED HOSPITAL SERVICES (AMS) reported Deferred State and Local Income Tax Expense (Benefit) of -$135.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-31.

Financial Statements › Expense Statement › Income Tax

us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit · last filed 2026-03-31

  • AMERICAN SHARED HOSPITAL SERVICES deferred state and local income tax expense (benefit) for fiscal 2025 was -$135.00K, a 550.00% decline from fiscal 2024.
  • AMERICAN SHARED HOSPITAL SERVICES deferred state and local income tax expense (benefit) for fiscal 2024 was $30.00K.
  • AMERICAN SHARED HOSPITAL SERVICES deferred state and local income tax expense (benefit) for fiscal 2023 was -$77.00K, a 260.42% decline from fiscal 2022.
  • AMERICAN SHARED HOSPITAL SERVICES deferred state and local income tax expense (benefit) for fiscal 2022 was $48.00K.
Period endDeferred State and Local Income Tax Expense (Benefit) 12 month
2025-12-31-$135.00K
10-K · filed 2026-03-31
2024-12-31$30.00K
10-K · filed 2026-03-31
2023-12-31-$77.00K
10-K · filed 2025-04-04
2022-12-31$48.00K
10-K · filed 2024-04-01
2021-12-31-$18.00K
10-K · filed 2023-03-31
2020-12-31-$266.00K
10-K · filed 2022-03-30
2019-12-31-$251.00K
10-K · filed 2021-04-06
2018-12-31-$210.00K
10-K · filed 2020-04-03
2017-12-31$68.00K
10-K · filed 2020-04-03
2016-12-31$93.00K
10-K · filed 2019-03-29
2015-12-31-$57.00K
10-K · filed 2018-03-28
2014-12-31$40.00K
10-K · filed 2017-03-27
2013-12-31$12.00K
10-K · filed 2016-03-30
2012-12-31-$41.00K
10-K · filed 2015-04-01
2011-12-31-$229.00K
10-K · filed 2014-03-31
2010-12-31$26.00K
10-K · filed 2013-03-29

Similar stocks

Stock NameCountryMarket CapPE Ratio
Advanced Biomed Inc. (ADVB)$0.009B
Aclarion, Inc. (ACON)United States$0.008B
BioNexus Gene Lab Corp (BGLC)$0.004B
SERA PROGNOSTICS, INC. (SERA)United States$0.062B-5.75
Freenome, Inc. (FRNM)United States$0.143B
EXAGEN INC. (XGN)United States$0.212B-5.95
BIODESIX INC (BDSX)United States$0.312B
Fulgent Genetics, Inc. (FLGT)United States$0.593B-6.70
Lumexa Imaging Holdings, Inc. (LMRI)United States$0.951B
CASTLE BIOSCIENCES INC (CSTL)United States$1.074B-37.45